Randolph Seth Watnick, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thrombospondin 1 | 8 | 2016 | 254 | 2.190 |
Why?
|
Saposins | 2 | 2016 | 16 | 1.040 |
Why?
|
Neovascularization, Pathologic | 8 | 2014 | 2767 | 0.570 |
Why?
|
G-Protein-Coupled Receptor Kinase 3 | 1 | 2014 | 8 | 0.560 |
Why?
|
Tumor Microenvironment | 3 | 2016 | 2503 | 0.520 |
Why?
|
Peptides, Cyclic | 1 | 2016 | 450 | 0.510 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2016 | 499 | 0.440 |
Why?
|
Paracrine Communication | 2 | 2009 | 298 | 0.420 |
Why?
|
Neoplasm Metastasis | 3 | 2014 | 5391 | 0.410 |
Why?
|
Endocrine Cells | 1 | 2009 | 12 | 0.410 |
Why?
|
Peptide Elongation Factors | 2 | 1999 | 65 | 0.380 |
Why?
|
Vascular Endothelial Growth Factor A | 8 | 2018 | 3429 | 0.380 |
Why?
|
Fibroblasts | 3 | 2014 | 4345 | 0.350 |
Why?
|
Viral Proteins | 4 | 2004 | 1996 | 0.340 |
Why?
|
Stromal Cells | 2 | 2012 | 1385 | 0.340 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2014 | 2912 | 0.290 |
Why?
|
ras Proteins | 2 | 2014 | 1141 | 0.260 |
Why?
|
Epithelial Cells | 2 | 2014 | 3715 | 0.240 |
Why?
|
Bacteriophage lambda | 2 | 1999 | 160 | 0.230 |
Why?
|
Terminator Regions, Genetic | 1 | 2000 | 24 | 0.210 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4648 | 0.190 |
Why?
|
Coliphages | 1 | 1998 | 122 | 0.180 |
Why?
|
Zinc | 2 | 2000 | 693 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2018 | 579 | 0.180 |
Why?
|
Tryptophan | 1 | 2000 | 460 | 0.170 |
Why?
|
Bacteriophages | 1 | 2000 | 331 | 0.170 |
Why?
|
Hormones | 2 | 2012 | 777 | 0.160 |
Why?
|
Cyclization | 1 | 2016 | 95 | 0.160 |
Why?
|
Transcription, Genetic | 3 | 2000 | 8130 | 0.160 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2012 | 858 | 0.150 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1998 | 485 | 0.150 |
Why?
|
Chemokine CCL5 | 1 | 2015 | 218 | 0.150 |
Why?
|
Fibroblast Growth Factor 2 | 3 | 2012 | 639 | 0.140 |
Why?
|
Down-Regulation | 2 | 2014 | 3226 | 0.140 |
Why?
|
Transcription Factors | 3 | 2000 | 11910 | 0.140 |
Why?
|
Plasminogen Activator Inhibitor 2 | 1 | 2014 | 20 | 0.140 |
Why?
|
Neoplasms | 3 | 2013 | 19538 | 0.140 |
Why?
|
E2F1 Transcription Factor | 1 | 2014 | 185 | 0.140 |
Why?
|
Pneumonectomy | 2 | 2018 | 1066 | 0.130 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 594 | 0.130 |
Why?
|
Skin Pigmentation | 1 | 2014 | 281 | 0.120 |
Why?
|
DNA, Viral | 1 | 1999 | 2341 | 0.120 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2012 | 66 | 0.120 |
Why?
|
Cell Proliferation | 5 | 2018 | 10990 | 0.120 |
Why?
|
Megakaryocytes | 1 | 2015 | 511 | 0.120 |
Why?
|
Cell Line, Tumor | 7 | 2016 | 17251 | 0.120 |
Why?
|
Antigens, Ly | 1 | 2013 | 308 | 0.120 |
Why?
|
Chemokine CCL2 | 1 | 2014 | 671 | 0.110 |
Why?
|
Liposarcoma | 1 | 2014 | 314 | 0.110 |
Why?
|
Prostatic Neoplasms | 1 | 2014 | 10439 | 0.110 |
Why?
|
Melanocytes | 1 | 2014 | 578 | 0.110 |
Why?
|
Retinoblastoma Protein | 1 | 2014 | 708 | 0.110 |
Why?
|
Heparin | 1 | 2018 | 1679 | 0.110 |
Why?
|
Cell Death | 1 | 2016 | 1769 | 0.100 |
Why?
|
Matrix Metalloproteinases | 1 | 2012 | 399 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2014 | 2833 | 0.100 |
Why?
|
Amino Acids | 1 | 2016 | 1717 | 0.100 |
Why?
|
Lung | 2 | 2018 | 9182 | 0.100 |
Why?
|
Templates, Genetic | 2 | 2000 | 269 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 3983 | 0.100 |
Why?
|
Mice, Inbred C57BL | 5 | 2018 | 23439 | 0.100 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2012 | 594 | 0.090 |
Why?
|
Escherichia coli | 2 | 1999 | 4411 | 0.090 |
Why?
|
Cell Survival | 2 | 2018 | 6288 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 1998 | 1961 | 0.090 |
Why?
|
Transcriptional Elongation Factors | 2 | 1999 | 155 | 0.090 |
Why?
|
Signal Transduction | 5 | 2018 | 24351 | 0.090 |
Why?
|
Bone Marrow Cells | 2 | 2013 | 2698 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3881 | 0.080 |
Why?
|
Bacterial Proteins | 2 | 1999 | 4155 | 0.080 |
Why?
|
DNA-Directed RNA Polymerases | 2 | 1999 | 382 | 0.080 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2008 | 641 | 0.070 |
Why?
|
Regression Analysis | 1 | 2016 | 6669 | 0.070 |
Why?
|
Cell Communication | 1 | 2012 | 1658 | 0.070 |
Why?
|
RNA, Messenger | 2 | 2004 | 13469 | 0.070 |
Why?
|
Blood Platelets | 1 | 2015 | 2446 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3789 | 0.070 |
Why?
|
Organ Specificity | 1 | 2009 | 2115 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2009 | 1042 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2014 | 20620 | 0.060 |
Why?
|
Burkitt Lymphoma | 1 | 2004 | 358 | 0.060 |
Why?
|
Mice | 10 | 2018 | 80803 | 0.060 |
Why?
|
Transplantation, Heterologous | 2 | 2012 | 2159 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2000 | 14656 | 0.060 |
Why?
|
Animals | 11 | 2018 | 170849 | 0.060 |
Why?
|
Protein Binding | 3 | 2000 | 9947 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 3053 | 0.060 |
Why?
|
rho-Associated Kinases | 1 | 2003 | 276 | 0.060 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2003 | 774 | 0.060 |
Why?
|
Escherichia coli Proteins | 2 | 1999 | 1134 | 0.060 |
Why?
|
Cell Line, Transformed | 1 | 2003 | 1026 | 0.050 |
Why?
|
rho GTP-Binding Proteins | 1 | 2003 | 300 | 0.050 |
Why?
|
Molecular Sequence Data | 3 | 2000 | 19328 | 0.050 |
Why?
|
Cell Transplantation | 1 | 2003 | 495 | 0.050 |
Why?
|
Mice, SCID | 3 | 2014 | 2913 | 0.050 |
Why?
|
Phenanthrolines | 1 | 1999 | 57 | 0.050 |
Why?
|
Dithiothreitol | 1 | 1999 | 113 | 0.050 |
Why?
|
Endothelial Growth Factors | 1 | 2003 | 704 | 0.050 |
Why?
|
Osteosarcoma | 1 | 2006 | 904 | 0.050 |
Why?
|
RNA, Viral | 2 | 1999 | 2823 | 0.050 |
Why?
|
Humans | 16 | 2018 | 686663 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2008 | 1977 | 0.050 |
Why?
|
Azides | 1 | 1999 | 127 | 0.050 |
Why?
|
Genes, ras | 1 | 2003 | 728 | 0.050 |
Why?
|
Lymphokines | 1 | 2003 | 986 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1372 | 0.050 |
Why?
|
Histidine | 1 | 2000 | 340 | 0.050 |
Why?
|
Herpesvirus 4, Human | 1 | 2004 | 1221 | 0.050 |
Why?
|
Surface-Active Agents | 1 | 2018 | 155 | 0.050 |
Why?
|
Genes, Tumor Suppressor | 1 | 2003 | 1111 | 0.040 |
Why?
|
DNA, Single-Stranded | 1 | 2000 | 400 | 0.040 |
Why?
|
Half-Life | 1 | 2018 | 691 | 0.040 |
Why?
|
Hirudins | 1 | 2018 | 190 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2012 | 8895 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 2004 | 2091 | 0.040 |
Why?
|
Disease Progression | 1 | 2014 | 13204 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18495 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2003 | 3969 | 0.040 |
Why?
|
Cross-Linking Reagents | 1 | 1999 | 769 | 0.040 |
Why?
|
Cyclohexanes | 1 | 2015 | 156 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 575 | 0.040 |
Why?
|
DNA Primers | 1 | 2000 | 3121 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1799 | 0.040 |
Why?
|
Pigmentation | 1 | 2014 | 172 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2018 | 1709 | 0.030 |
Why?
|
Receptors, CCR5 | 1 | 2015 | 449 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 427 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 4076 | 0.030 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2014 | 286 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1154 | 0.030 |
Why?
|
Cell Line | 2 | 2008 | 17137 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2012 | 137 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2003 | 3006 | 0.030 |
Why?
|
NF-kappa B | 2 | 2014 | 2553 | 0.030 |
Why?
|
Proteoglycans | 1 | 2014 | 865 | 0.030 |
Why?
|
Glioblastoma | 1 | 2006 | 3271 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2018 | 1447 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2014 | 830 | 0.030 |
Why?
|
Microcirculation | 1 | 2014 | 1296 | 0.020 |
Why?
|
Triazoles | 1 | 2015 | 931 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2000 | 3686 | 0.020 |
Why?
|
Binding Sites | 1 | 1998 | 6499 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2006 | 6450 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 7060 | 0.020 |
Why?
|
Base Sequence | 1 | 2000 | 13729 | 0.020 |
Why?
|
Pyridines | 1 | 1999 | 2843 | 0.020 |
Why?
|
Oligopeptides | 1 | 2013 | 1305 | 0.020 |
Why?
|
Male | 5 | 2018 | 352465 | 0.020 |
Why?
|
Models, Biological | 1 | 2003 | 10102 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 11616 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 19153 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2018 | 5167 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6786 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2006 | 672 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 5114 | 0.020 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2004 | 267 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5678 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 4129 | 0.020 |
Why?
|
Phenotype | 2 | 2014 | 16091 | 0.020 |
Why?
|
Immunoblotting | 1 | 2006 | 1840 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2014 | 3196 | 0.010 |
Why?
|
Female | 3 | 2016 | 375459 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 8182 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 10094 | 0.010 |
Why?
|
African Americans | 1 | 2014 | 5144 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2006 | 6835 | 0.010 |
Why?
|
Time Factors | 2 | 2012 | 42271 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9661 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 12095 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2008 | 8262 | 0.010 |
Why?
|